明德生物：披露重大资产重组进展

Group 1 - The company Mingde Bio is planning to acquire 100% equity of Wuhan Bikaier Rescue Supplies Co., Ltd. from Bluefan Medical Co., Ltd. through a cash transaction [1] - This transaction is expected to constitute a major asset restructuring but will not lead to a restructuring listing, involve share issuance, or constitute a related party transaction [1] - The company is currently advancing auditing, evaluation, and due diligence processes, and no formal agreement has been signed yet; the specific plan is still under discussion [1]